Cannabis Law Report

JULY 25, 2022

million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). The state agency grant funding followed the successful completion of a phase 1 clinical trial in 80 healthy participants.

Microdosing 52

Microdosing Clinical Trials Research and Development Data 52

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

JULY 9, 2022

Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. For Thornton, however, microdosing psilocybin mushrooms was a question of life or death. “I I decided to try microdosing psilocybin for depression because nothing else was working for me,” explains Thornton. “I

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

Cannabis Law Report

JUNE 19, 2022

For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. Originally Published At Microdose. However, that does not mean that the path to patents is closed off.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

FEBRUARY 9, 2022

“It is kind of a landmark moment because Oregon is the very first state to have created such a system of regulation,” said Mason Marks, a member of Oregon’s psilocybin advisory board and a senior fellow on the Project on Psychedelics Law and Regulation at Harvard Law School. Other more complicated issues still need to be decided.

Clinical Trials 52

Clinical Trials Microdosing Safety Conditions 52

Cannabis Law Report

JUNE 4, 2021

Legislative initiatives (introduction and support of changes of laws). Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Mr Psychedelic Law & Iter Investments.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51